Cefadroxil/cefadroxil hemihydrate - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for cefadroxil/cefadroxil hemihydrate and what is the scope of freedom to operate?
Cefadroxil/cefadroxil hemihydrate
is the generic ingredient in three branded drugs marketed by Aurobindo Pharma, Chartwell Rx, Cspc Ouyi, Hikma, Ivax Sub Teva Pharms, Lupin, Purepac Pharm, Ranbaxy Labs Ltd, Sandoz, Teva, Teva Pharms, Warner Chilcott, Bristol, Ani Pharms, Apothecon, Aurobindo, Hikma Pharms, Sun Pharm Inds Ltd, and Ranbaxy, and is included in thirty NDAs. Additional information is available in the individual branded drug profile pages.Twenty-two suppliers are listed for this compound.
Summary for cefadroxil/cefadroxil hemihydrate
US Patents: | 0 |
Tradenames: | 3 |
Applicants: | 19 |
NDAs: | 30 |
Finished Product Suppliers / Packagers: | 22 |
Raw Ingredient (Bulk) Api Vendors: | 69 |
Patent Applications: | 6,444 |
DailyMed Link: | cefadroxil/cefadroxil hemihydrate at DailyMed |
Pharmacology for cefadroxil/cefadroxil hemihydrate
Drug Class | Cephalosporin Antibacterial |
Anatomical Therapeutic Chemical (ATC) Classes for cefadroxil/cefadroxil hemihydrate
US Patents and Regulatory Information for cefadroxil/cefadroxil hemihydrate
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Teva | CEFADROXIL | cefadroxil/cefadroxil hemihydrate | CAPSULE;ORAL | 062695-001 | Feb 10, 1989 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Teva Pharms | CEFADROXIL | cefadroxil/cefadroxil hemihydrate | TABLET;ORAL | 062774-001 | Apr 8, 1987 | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Ranbaxy | CEFADROXIL | cefadroxil/cefadroxil hemihydrate | TABLET;ORAL | 065018-001 | Apr 23, 1999 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Sandoz | CEFADROXIL | cefadroxil/cefadroxil hemihydrate | CAPSULE;ORAL | 062291-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.